Moderate moisture levels such as greater than 3% but no greater than 7% may be beneficial for solid formulations of certain prostacyclin analogs. Accordingly a solid formulation containing a prostacyclin analog may be packaged inside a pharmaceutical packaging with such amount of a desiccant or a drying agent that after the storage the solid formulation may have a moderate level of moisture in it.
